I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 16 studies | 44% ± 16% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 16 studies | 44% ± 16% |
Insufficient scRNA-seq data for expression of UBXN10 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 100% | 544.51 | 89 / 89 | 84% | 9.64 | 754 / 901 |
| thymus | 99% | 787.76 | 644 / 653 | 82% | 15.26 | 495 / 605 |
| intestine | 97% | 1696.90 | 940 / 966 | 80% | 10.12 | 422 / 527 |
| bladder | 90% | 418.05 | 19 / 21 | 65% | 7.34 | 330 / 504 |
| breast | 64% | 249.74 | 296 / 459 | 77% | 14.50 | 864 / 1118 |
| lung | 80% | 764.93 | 462 / 578 | 58% | 8.79 | 667 / 1155 |
| adrenal gland | 90% | 293.10 | 233 / 258 | 43% | 3.80 | 98 / 230 |
| liver | 83% | 526.98 | 187 / 226 | 47% | 5.87 | 189 / 406 |
| esophagus | 83% | 1190.89 | 1196 / 1445 | 41% | 5.03 | 75 / 183 |
| uterus | 84% | 591.53 | 142 / 170 | 39% | 5.75 | 180 / 459 |
| ovary | 32% | 83.42 | 58 / 180 | 88% | 12.01 | 378 / 430 |
| stomach | 50% | 573.98 | 178 / 359 | 70% | 7.74 | 201 / 286 |
| brain | 87% | 462.76 | 2309 / 2642 | 24% | 2.93 | 170 / 705 |
| prostate | 84% | 477.19 | 205 / 245 | 27% | 1.42 | 137 / 502 |
| pancreas | 22% | 43.27 | 71 / 328 | 87% | 10.75 | 154 / 178 |
| ureter | 0% | 0 | 0 / 0 | 100% | 7.36 | 1 / 1 |
| skin | 33% | 74.56 | 597 / 1809 | 40% | 3.07 | 188 / 472 |
| heart | 64% | 289.04 | 551 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 55% | 2.93 | 44 / 80 |
| adipose | 34% | 84.67 | 409 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 5% | 13.32 | 46 / 929 | 0% | 0 | 0 / 0 |
| muscle | 4% | 10.30 | 36 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.11 | 1 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.14 | 1 / 45 |
| blood vessel | 2% | 4.25 | 25 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| GO_0060271 | Biological process | cilium assembly |
| GO_0036503 | Biological process | ERAD pathway |
| GO_0005929 | Cellular component | cilium |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0030992 | Cellular component | intraciliary transport particle B |
| GO_0005515 | Molecular function | protein binding |
| GO_0043130 | Molecular function | ubiquitin binding |
| Gene name | UBXN10 |
| Protein name | UBX domain-containing protein 10 (UBX domain-containing protein 3) UBXN10 protein |
| Synonyms | UBXD3 |
| Description | FUNCTION: VCP/p97-binding protein required for ciliogenesis . Acts as a tethering factor that facilitates recruitment of VCP/p97 to the intraflagellar transport complex B (IFT-B) in cilia . UBX domain-containing proteins act as tethering factors for VCP/p97 and may specify substrate specificity of VCP/p97 . . |
| Accessions | ENST00000375099.4 Q3ZCW1 Q96LJ8 |
